Efficacy and Safety of Bendamustine Plus Rituximab in Chronic Lympocytic Leukemia
NCT02491398
·
clinicaltrials.gov ↗
COMPLETED
Status
494
Enrollment
OTHER
Sponsor class
Conditions
Chronic Lymphocytic Leukemia
Interventions
DRUG:
Bendamustine + Rituximab
Sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto